These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22724)

  • 1. A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.
    Jenner P; Elliott PN; Clow A; Reavill C; Marsden CD
    J Pharm Pharmacol; 1978 Jan; 30(1):46-8. PubMed ID: 22724
    [No Abstract]   [Full Text] [Related]  

  • 2. Septo-hippocampal system: target for substituted benzamides.
    Bischoff S; Bittiger H; Delini-Stula A; Ortmann R
    Eur J Pharmacol; 1982 Apr; 79(3-4):225-32. PubMed ID: 7201401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 4. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic component of neuroleptic receptors.
    Leysen JE; Niemegeers CJ; Tollenaere JP; Laduron PM
    Nature; 1978 Mar; 272(5649):168-71. PubMed ID: 564466
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
    Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.
    Jenner P; Clow A; Reavill C; Theodorou A; Marsden CD
    Life Sci; 1978 Aug; 23(6):545-9. PubMed ID: 692279
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the mechanism of action of substituted benzamide drugs.
    Köhler C; Ogren SO; Fuxe K
    Acta Psychiatr Scand Suppl; 1984; 311():125-37. PubMed ID: 6142588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

  • 10. Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat.
    Fleminger S; van de Waterbeemd H; Rupniak NM; Reavill C; Testa B; Jenner P; Marsden CD
    J Pharm Pharmacol; 1983 Jun; 35(6):363-8. PubMed ID: 6135774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugs.
    Jenner P; Marsden CD
    Acta Psychiatr Scand Suppl; 1984; 311():109-23. PubMed ID: 6142587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms.
    Jenner P; Clow A; Reavill C; Theodorou A; Marsden CD
    J Pharm Pharmacol; 1980 Jan; 32(1):39-44. PubMed ID: 6102125
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
    Köhler C; Ogren SO; Haglund L; Angeby T
    Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenesis of dopamine receptor binding in the corpus striatum of the rat.
    Pardo JV; Creese I; Burt DR; Snyder SH
    Brain Res; 1977 Apr; 125(2):376-82. PubMed ID: 851885
    [No Abstract]   [Full Text] [Related]  

  • 15. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Nature; 1979 Mar; 278(5699):59-61. PubMed ID: 570253
    [No Abstract]   [Full Text] [Related]  

  • 16. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
    Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-dependent regulator involvement in the dopamine receptors supersensitivity.
    Lucchelli A
    Pharmacol Res Commun; 1980 Jul; 12(7):709-17. PubMed ID: 7190711
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum.
    Schwarcz R; Creese I; Coyle JT; Snyder SH
    Nature; 1978 Feb; 271(5647):766-8. PubMed ID: 625348
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of lipophilicity of substituted benzamides on the dopaminergic effects in vivo and in vitro.
    Hall H; Ogren SO; Florvall L
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):211-5. PubMed ID: 6542298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
    Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G
    Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.